Question 1

How many shares of INM does UBS Group AG own?

Accepted Answer

UBS Group AG previously held 0 shares of INM (INMED PHARMACEUTICALS INC) before exiting the position in 2026-Q2.

Question 2

What is UBS Group AG's INM position worth?

Accepted Answer

UBS Group AG's INM position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is UBS Group AG buying or selling INM?

Accepted Answer

In 2026-Q2, UBS Group AG exited their INM position entirely (-100.0% change in shares).

Question 4

When did UBS Group AG first buy INM?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in INM in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$1.55	0
2026-Q1	Increased	8,068	+2040.0%	$5,204	0.0%	$0.76	17
2025-Q4	New	377	-	$400	0.0%	$1.10	17
2025-Q3	Exited	0	-100.0%	$0	0.0%	$2.27	0
2025-Q2	Increased	7,762	+27.1%	$25,227	0.0%	$3.38	16
2025-Q1	Decreased	6,106	-41.3%	$12,639	0.0%	$2.06	0
2024-Q4	New	10,408	-	$49,334	0.0%	$4.59	31

INM7 quarters

INM
7 quarters